Table 2.
Resistance profile of K. pneumoniae isolates.
| Isolates | Antimicrobial resistance profile | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMC | PTZ | CXM | CRO | CFP | CPM | LVX | ETP | IPM | MEM | AMK | GEN | CIP | SXT | CL* | PB* | |
| BK1 | R | R | R | R | R | R | R | R | R | R | I | R | R | S | R | R |
| BK2 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| BK3 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| BK4 | R | R | R | R | R | R | R | R | R | R | I | R | R | S | R | R |
| BK5 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| BK6 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| BK7 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| BK9 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
| BK14 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R |
AMC, amoxicillin/clavulanic; PTZ, piperacillin/tazobactam; CXM, cefuroxime; CRO, ceftriaxone; CFP, cefoperazone; CPM, cefepime; LVX, levofloxacin; ETP, ertapenem; IPM, imipenem; MEM, meropenem; AMK, amikacin; GEN, gentamicin; CIP, ciprofloxacin; SXT, trimethoprim/sulfamethoxazole; CL, colistin; PB, polymyxin B; R, resistant; I, intermediate; S, susceptible.
*
Microbroth dilution method.